Immunosuppressive Treatment of Choroidal Neovascularization Associated With Endogenous Posterior Uveitis | Allergy and Clinical Immunology | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Forrester  WLiversidge  JDua  HSTowler  HMcMenamin  PG Comparison of clinical and experimental uveitis.  Curr Eye Res. 1990;975- 84Google ScholarCrossref
2.
Dreyer  RFOass  JDM Multifocal choroiditis and panuveitis.  Arch Ophthalmol. 1984;1021776- 1784Google ScholarCrossref
3.
Priem  HAOosterhuis  JA Birdshot chorioretinopathy: clinical characteristics and evolution.  Br J Ophthalmol. 1988;72646- 659Google ScholarCrossref
4.
Kilmartin  DForrester  JVDick  AD Cyclosporin A-induced resolution of choroidal neovascularization associated with sympathetic ophthalmia.  Arch Ophthalmol. 1998;116249- 250Google Scholar
5.
Reddy  VMZamora  RLKaplan  HJ Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome.  Am J Ophthalmol. 1995;120291- 301Google Scholar
6.
Woods  ACWahlen  HE The probable role of benign histoplasmosis in the etiology of granulomatous uveitis.  Am J Ophthalmol. 1960;49205- 220Google Scholar
7.
Saraux  HLefrançois  AOffret  H La choroidopathie maculaire hemorragique du sujetjeune ou pseudo-histoplamose.  J Fr Ophtalmol. 1979;2349- 354Google Scholar
8.
Flage  TSand  ABSyrdalen  P Haemorrhagic maculopathy in young adults.  Acta Ophthalmol (Copenh). 1977;55489- 496Google ScholarCrossref
9.
Scheider  A Multifocal inner choroiditis.  Ger J Ophthalmol. 1993;21- 9Google Scholar
10.
Watzke  RCClaussen  RW The long-term course of multifocal choroiditis (presumed ocular histoplasmosis).  Am J Ophthalmol. 1981;91750- 760Google Scholar
11.
Parvan  PRMargo  CE Submacular neovascular membrane and focal granulomatous inflammation.  Ophthalmology. 1996;103586- 589Google ScholarCrossref
12.
Saxe  SJGrossniklavas  HELopez  PFLambert  HMSternberg  P  JrL'Hernault  N Ultrastructural features of surgically excised subretinal neovascular membranes in the ocular histoplasmosis syndrome.  Arch Ophthalmol. 1993;11188- 95Google ScholarCrossref
13.
Suttorp-Schulten  MSABollemeijer  JGBos  PJMRothova  A Presumed ocular histoplasmosis in the Netherlands: an area without histoplasmosis.  Br J Ophthalmol. 1997;817- 11Google ScholarCrossref
14.
Bloch-Michel  ENussenblatt  RB International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease.  Am J Ophthalmol. 1987;103234- 235Google Scholar
15.
Macular Photocoagulation Study Group, Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis: results of a randomized clinical trial.  Arch Ophthalmol. 1987;1051499- 1507Google ScholarCrossref
16.
Nussenblatt  RBPalestine  AGChan  CC Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents.  Am J Ophthalmol. 1983;96275- 282Google Scholar
17.
Nussenblatt  RBGery  IWeiner  HL  et al.  A masked, randomized dose-response study between Cyclosporin A and G in the treatment of sight-threatening uveitis of noninfectious origin.  Am J Ophthalmol. 1993;115583- 591Google Scholar
18.
Towler  HMAWhiting  PHForrester  W Combination low dose Cyclosporin A and steroid therapy in intraocular inflammation.  Eye. 1990;4514- 520Google ScholarCrossref
19.
Campochiaro  PAMorgan  KMConway  BPStathos  J Spontaneous involution of subfoveal neovascularization.  Am J Ophthalmol. 1990;109668- 675Google Scholar
20.
Macular Photocoagulation Study Group, Laser photocoagulation for juxtafoveal choroidal neovascularisation: five-year results.  Arch Ophthalmol. 1994;112500- 509Google ScholarCrossref
21.
Olk  RJBurgess  DBMcCormick  PA Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome: visual prognosis.  Ophthalmology. 1984;911592- 1602Google ScholarCrossref
22.
Macular Photocoagulation Study Group, The influence of treatment extent on the visual acuity of eyes treated with krypton laser for juxtafoveal choroidal neovascularization.  Arch Ophthalmol. 1995;113190- 194Google ScholarCrossref
23.
Macular Photocoagulation Study Group, Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis.  Arch Ophthalmol. 1989;107344- 352Google ScholarCrossref
24.
Gass  JD Biomicroscopic and histopathologic considerations regarding the feasability of surgical excision of subfoveal neovascular membranes.  Am J Ophthalmol. 1994;118285- 298Google Scholar
25.
Holekamp  NMThomas  MADickinson  JDValluri  S Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis.  Ophthalmology. 1997;10422- 26Google ScholarCrossref
26.
Melberg  NSThomas  MADickinson  JDValluri  S Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome.  Ophthalmology. 1996;1031064- 1067Google ScholarCrossref
Clinical Sciences
November 1998

Immunosuppressive Treatment of Choroidal Neovascularization Associated With Endogenous Posterior Uveitis

Author Affiliations

From the Eye Department, Aberdeen Royal Infirmary (Drs Dees and Arnold) and the Department of Ophthalmology, University of Aberdeen (Drs Forrester and Dick), Aberdeen, Scotland.

Arch Ophthalmol. 1998;116(11):1456-1461. doi:10.1001/archopht.116.11.1456
Abstract

Objective  To determine whether resolution of choroidal neovascularization (CNV), a recognized sight-threatening complication of endogenous posterior uveitis, and maintenance of vision could be achieved with immunosuppression.

Patients and Methods  Fourteen patients (17 eyes) with CNV associated with endogenous posterior uveitis were enrolled in an open study. Ages ranged from 5 to 51 years. Three eyes had extrafoveal CNV, 6 juxtafoveal, and 8 subfoveal. Three patients were treated with a single course of oral corticosteroids, 2 had additional cyclosporine for up to 2 years, and 9 continued to receive a low-dose regimen of a combination of immunosuppressive drugs.

Results  After a median follow-up of 15 months (range, 7 months to 612 years), 9 of 17 eyes had an improvement in visual acuity; 6 remained within 1 Snellen line of initial visual acuity, and 2 had lost 2 Snellen lines. Angiographically, CNV resolved in 13 eyes, resolved then recurred in 3, and improved but persisted in 4.

Conclusion  These results support a role for immunosuppressive therapy in the treatment of CNV associated with endogenous posterior uveitis.

×